On Friday, Genedrive PLC (AIM:GDR), a company specializing in point-of-care pharmacogenetic testing, announced that it will release its preliminary results for the fiscal year that ended on June 30, 2024. The results will be made public on Friday, November 29, 2024. Following the announcement of the results, the company is set to provide a detailed presentation.
The presentation will be conducted live and is scheduled for Monday, December 2, 2024, at 2 pm GMT. Genedrive's CEO, Gino Miele, and CFO, Russ Shaw, will be presenting the results and providing insights into the company's performance and future outlook.
Investors and interested parties will be able to join the presentation through the digital platform Investor Meet Company. The platform offers free registration to users and allows them to directly add Genedrive PLC to their meeting schedule.
The company has provided a link for registration: https://www.investormeetcompany.com/genedrive-plc/register-investor, which enables investors to sign up and participate in the upcoming live presentation. Further details regarding the event will be available through the same platform.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.